Neurology

FieldLine Launches HEDscan™, a Next-Generation Device for Non-Invasive Functional Brain Imaging

FieldLine Launches HEDscan™, a Next-Generation Device for Non-Invasive Functional Brain Imaging

FieldLine Inc., a biotech company targeting advanced brain diagnostic technology, announced today the general availability of the FieldLine HEDscan system — the world's first commercially available non-cryogenic, whole-head magnetoencephalography (MEG) system for functional brain imaging. HEDscan is available to researchers…

European multicentre study – first expectations fulfilled

European multicentre study – first expectations fulfilled

The pathway to a correct diagnosis in epilepsy patients is often very long. Furthermore, approx. 30% of all patients with epilepsy cannot be treated adequately in spite of a variety of medicinal options. The use of technical options for treatment…

Epygenix Therapeutics Submits Investigational New Drug Application for EPX-100 to the U.S. FDA for the Treatment of Patients With Dravet Syndrome

Epygenix Therapeutics Submits Investigational New Drug Application for EPX-100 to the U.S. FDA for the Treatment of Patients With Dravet Syndrome

​​​Epygenix Therapeutics, Inc., a privately held biopharmaceutical company developing precision medicines for Dravet Syndrome, announced today that the Company has submitted Investigational New Drug Application (IND) and Fast Track Designation Request for EPX-100 to the U.S. Food and Drug Administration…

Regenetek Research Defends Suspended Physician Against College Findings

Regenetek Research Defends Suspended Physician Against College Findings

​​Dr. Susan Krause, who has had a successful, peer-awarded 35-year career as a physician and educator, has been suspended by The College of Physicians and Surgeons of Manitoba (CPSM) after an investigation of her involvement in an experimental Multiple Sclerosis…

Sooma Medical Awarded US Patent for Advanced Stimulation Electrode

Sooma Medical Awarded US Patent for Advanced Stimulation Electrode

Sooma Medical announces receipt of a U.S. patent for its new stimulation electrode. The electrode technology is essential for safe and effective delivery of all neuromodulation therapies. The electrode technology developed by Sooma R&D team dramatically reduces the resistance in the skin-electrode interface when compared to…

Longevity Biotech Initiates Clinical Neuroinflammation Biomarker Study at the Department of Veterans Affairs to Investigate Immune Related Aspects of Parkinson's Disease With Continued Support From the Michael J. Fox Foundation

Longevity Biotech, Inc. (LBT) is launching a new clinical study to identify specific immune and inflammatory markers that could potentially be used to both diagnose Parkinson’s disease (PD) and stratify patients by stage of disease. The clinical study will be initially…

Journal of Neuroimaging Publishes Study on MRIs Showing LearningRx Brain Training Produced Changes in Brain Connectivity

The results of a study published in the Journal of Neuroimaging highlight the benefits of LearningRx’s ThinkRx Personal Brain Training as seen in MRIs that demonstrate changes in brain connectivity. ThinkRx is an intensive, 60+ hour, one-on-one, clinician-delivered cognitive training…

Xavant Technology Set to Disrupt Neuropathic Pain Treatment in the UK

Xavant Technology (Pty) Ltd today announced the launch of their Stimpod NMS460 in the U.K. The Stimpod NMS460, a non-invasive neuromodulation device, is focused on the symptomatic relief and management of neuropathic pain as well as an adjunctive treatment in…

'Journal of Neuroimaging' Publishes Research Showing LearningRx Brain Training Produced Significant Cognitive Gains for Soldiers With TBI and ABI

The results of a study published in "Journal of Neuroimaging" highlight the benefits of LearningRx’s ThinkRx one-on-one cognitive training program in improving cognitive skills in soldiers with moderate to severe traumatic brain injury (TBI) and acquired brain injury (ABI). In…

The Eustache Institute Are Successfully Treating Patients Who Suffer From Alzheimer's Disease and Dementia With Neurofeedback Therapy

The Eustache Institute Are Successfully Treating Patients Who Suffer From Alzheimer's Disease and Dementia With Neurofeedback Therapy

Dr. Elena Eustache, the founder of the Eustache Institute, has successfully helped patients who suffer from Alzheimer's disease, improve their quality of life with Neurofeedback therapy. This mode of treatment helps control the symptoms related to the illness while preventing…

Franchise Site Reviews LearningRx Child Educational Franchise as Top Franchise in 2018

Franchise Site Reviews LearningRx Child Educational Franchise as Top Franchise in 2018

​Franchise Gator (www.franchisegator.com) has once again named LearningRx to its list of Top 100 Franchises, with a ranking of No. 66. The selection process includes independent analysis of things like risk reduction, investment range and industry. According to Franchise Gator,…

OssDsign Accelerates Commercial Efforts in the US

OssDsign is active on the US neurosurgical implants market with its lead product OSSDSIGN Cranial PSI, a calcium-phosphate based implant for cranioplasty. Since March 2017, OssDsign has a commercial partnership with California-based Matador Medical Inc who acts as master distributor…

LearningRx Reviews New Study That Finds Adolescents' Brains React More Responsively to Rewards

LearningRx Reviews New Study That Finds Adolescents' Brains React More Responsively to Rewards

New research published in Nature Communications has found that adolescents’ brains react more responsively to receiving rewards. This strong reward system can be used to make learning easier. It’s something that LearningRx, the world’s largest one-on-one brain training company, has…

LearningRx Reviews American Academy of Neurology's New Recommendations for MCI: Cognitive Training and Exercise

LearningRx Reviews American Academy of Neurology's New Recommendations for MCI: Cognitive Training and Exercise

The American Academy of Neurology has just updated its 2001 practice guidelines for treating mild cognitive impairment (MCI). While medicine is no longer recommended, exercise and cognitive training are. “No high-quality evidence exists to support pharmacologic treatments for MCI,” says…

LearningRx Reviews: How Fast to President Trump in Presidents Day Contest

LearningRx Reviews: How Fast to President Trump in Presidents Day Contest

LearningRx is looking for the best, funniest, and most impressive memory feats for a national Presidents Day video contest. LearningRx is looking for videos of people quickly reciting, from memory, all 45 U.S. presidents in order while performing other tasks and…

CMSC Receives Interprofessional Continuing Education  Joint Accreditation for the Healthcare Team

CMSC Receives Interprofessional Continuing Education Joint Accreditation for the Healthcare Team

​The Consortium of Multiple Sclerosis Centers (CMSC) is pleased to announce that it has received the maximum six-year accreditation as a provider of Interprofessional Continuing Education (IPCE).  As a jointly accredited provider, CMSC can now offer education and CE credits…

Modius Raises $1.5m Across 80 Countries on Indiegogo, Pushing First-Ever, Non-Invasive Weight Management Headset to Market

Modius Raises $1.5m Across 80 Countries on Indiegogo, Pushing First-Ever, Non-Invasive Weight Management Headset to Market

Neurovalens, the company behind the revolutionary weight management wearable headset, Modius, is proud to announce the successful completion of their first-ever Indiegogo campaign. The campaign surpassed its target goal of $50,000 in just four hours, and, in total, raised $1.57 million…

The Next Step in Treating Gait and Walking Functions in Older Adults

The Next Step in Treating Gait and Walking Functions in Older Adults

​​​​Gait, or the way one walks, is a critical aspect of our lives as it defines our capacity to walk and keep our balance. Gait impairments and dementia often coexist in older adults and patients with neurodegenerative diseases. Both conditions…

Discovery Offers New Hope to Repair Spinal Cord Injuries

Discovery Offers New Hope to Repair Spinal Cord Injuries

Scientists at the Gladstone Institutes created a special type of neuron from human stem cells that could potentially repair spinal cord injuries. These cells, called V2a interneurons, transmit signals in the spinal cord to help control movement. When the researchers…

Drug and Alcohol Addiction: The Missing Link is NAD

Drug and Alcohol Addiction: The Missing Link is NAD

Alcohol and Drug addiction affects millions on a daily basis. NAD, a proven IV Therapy, has been studied by Harvard Medicine and is known to have an 87% success rate. A Harvard-proven biological medicine treatment says “NAD therapy is the…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login